Condition: Subarachnoid Hemorrhage, Aneurysmal · Sponsor: Edge Therapeutics Inc
This study compares EG-1962 to enteral nimodipine in the treatment of aneurysmal subarachnoid hemorrhage.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham Hospital | Birmingham, Alabama, United States | — |
| Dignity Health; St. Joseph's Hospital and Medical Center | Phoenix, Arizona, United States | — |
| University of California, San Francisco-Fresno | Fresno, California, United States | — |
| Keck Hospital of USC | Los Angeles, California, United States | — |
| Cedars-Sinai Medical Center | Los Angeles, California, United States | — |
| David Geffen School of Medicine at UCLA | Los Angeles, California, United States | — |
| UCSF | San Francisco, California, United States | — |
| Yale New Haven Hospital (YNHH) | New Haven, Connecticut, United States | — |
| UF Health Shands Florida | Gainesville, Florida, United States | — |
| Baptist Medical Center/Lyerly Neurosurgery | Jacksonville, Florida, United States | — |
| Mayo Clinic Florida | Jacksonville, Florida, United States | — |
| Tallahassee Neurological Clinic | Tallahassee, Florida, United States | — |
+ 67 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02790632